Diagnosing Pulmonary Tuberculosis by Using Sequence-Specific Purification of Urine Cell-Free DNA

Author:

Oreskovic Amy1ORCID,Panpradist Nuttada1,Marangu Diana2,Ngwane M. William3,Magcaba Zanele P.3,Ngcobo Sindiswa3,Ngcobo Zinhle3,Horne David J.45,Wilson Douglas P. K.36,Shapiro Adrienne E.45,Drain Paul K.45ORCID,Lutz Barry R.1

Affiliation:

1. Department of Bioengineering, University of Washington, Seattle, Washington, USA

2. Department of Paediatrics and Child Health, University of Nairobi, Nairobi, Kenya

3. Umkhuseli Innovation and Research Management, Pietermaritzburg, South Africa

4. Department of Medicine, University of Washington, Seattle, Washington, USA

5. Department of Global Health, University of Washington, Seattle, Washington, USA

6. Edendale Hospital, University of KwaZulu-Natal, Pietermaritzburg, South Africa

Abstract

Transrenal urine cell-free DNA (cfDNA) is a promising tuberculosis (TB) biomarker, but is challenging to detect because of the short length (<100 bp) and low concentration of TB-specific fragments. We aimed to improve the diagnostic sensitivity of TB urine cfDNA by increasing recovery of short fragments during sample preparation.

Funder

Bill and Melinda Gates Foundation

HHS | NIH | National Institute of Allergy and Infectious Diseases

National Science Foundation

UW | Center for AIDS Research, University of Washington

Publisher

American Society for Microbiology

Subject

Microbiology (medical)

Reference51 articles.

1. World Health Organization. 2020. Global tuberculosis report 2020. World Health Organization Geneva Switzerland.

2. Xpert MTB/RIF and Xpert MTB/RIF Ultra for pulmonary tuberculosis and rifampicin resistance in adults

3. Xpert MTB/RIF assay for the diagnosis of pulmonary tuberculosis in children: a systematic review and meta-analysis

4. Xpert® MTB/RIF assay for extrapulmonary tuberculosis and rifampicin resistance

5. World Health Organization. 2014. High-priority target product profiles for new tuberculosis diagnostics: report of a consensus meeting. World Health Organization Geneva Switzerland.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3